Confronto
Icatibant vs. Lanreotid
Due peptidi a confronto — identità, base di evidenze, stato legale ed eventi avversi noti.
Identità
Categoria
Ricerca (altro)
Ricerca (altro)
N. CAS
138614-30-9
108736-35-2
Peso molecolare
1304.52 g/mol
1096.34 g/mol
Emivita
nessun dato
nessun dato
Sequenza
nessun dato
nessun dato
Meccanismo d'azione
Icatibant
Icatibant competitively blocks the bradykinin B2 receptor. Because bradykinin mediates the vascular permeability, swelling and pain typical of hereditary angioedema, the blockade interrupts the acute attack.
Lanreotid
Lanreotide activates somatostatin receptors (chiefly SSTR2, additionally SSTR5), thereby suppressing the release of growth hormone, IGF-1 and various gastrointestinal and neuroendocrine hormones. It is metabolically far more stable than natural somatostatin.
Base di evidenze
Evidenza più alta
RCT sull'uomo
RCT sull'uomo
Studi
1
1
di cui sull'uomo
1
1
Effetti registrati
1
2
Contraddizioni aperte
0
1
Eventi avversi documentati
1
2
Stato legale
Voci complete
Frequently asked questions
- What is the difference between Icatibant and Lanreotid?
- Icatibant is classified as "Ricerca (altro)", while Lanreotid is classified as "Ricerca (altro)". Icatibant: Icatibant is a synthetic decapeptide and selective antagonist of the bradykinin B2 receptor. It is approved to treat acute attacks of hereditary angioedema (HAE). Lanreotid: Lanreotide is a synthetic cyclic octapeptide analog of somatostatin. It binds preferentially to the somatostatin receptors SSTR2 and SSTR5 and is approved for treating acromegaly and certain neuroendocrine tumours. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Icatibant or Lanreotid?
- The highest available evidence level is "RCT sull'uomo" for Icatibant and "RCT sull'uomo" for Lanreotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Icatibant and Lanreotid in Germany and the United States?
- Germania: Icatibant — Su prescrizione, Lanreotid — Su prescrizione. Stati Uniti: Icatibant — Su prescrizione, Lanreotid — Su prescrizione. These are factual summaries with source and review date on the individual pages.